Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00753298
Other study ID # YA-CLO-0002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2007
Est. completion date March 2008

Study information

Verified date September 2012
Source Wellspect HealthCare
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is designed as a randomized, double-blind, parallel-group, multi centre study comparing perception and tolerability of investigational product and comparator. In the randomized part of the study the subjects will be given either LoFric Primo (POBE) or the comparator LoFric Primo (PVC) for use over 4 weeks. The hypothesis is that subject perception and satisfaction of POBE is equal to or better than for PVC.


Recruitment information / eligibility

Status Completed
Enrollment 195
Est. completion date March 2008
Est. primary completion date March 2008
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Provision of informed consent - Males and females aged 18 years and over - Experienced users of LoFric Primo with a minimum of one month of use - Practice CIC with LoFric Primo at least 3 times per day - Adults able to read, write and understand information given to them regarding the study Exclusion Criteria: - Ongoing symptomatic UTI - Suspicions of possible poor compliance with CIC during the study period - Previous enrolment or randomisation of treatment in the present study - Pregnancy - Subjects not able to perform self-catheterisation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
LoFric Primo (POBE) single-use urinary catheter
LoFric Primo (POBE) single-use urinary catheter
LoFric Primo (PVC) single-use urinary catheter
LoFric Primo (PVC) single-use urinary catheter

Locations

Country Name City State
Austria Medical University of Vienna, Department of Urology Vienna
Germany NRZ Greifswald Greifswald
Germany Kliniken Maria Hilf GmbH, Zentrum für Kontinenz und Neuro-Urologie, Krankenhaus St. Franziskus Mönchengladbach
Germany BG-Klinik Tübingen Tübingen
Italy Ospedale Careggi, Unità Spinale Firenze
Italy Primario U.O. Neuro-Urologia, Direttore Dipartimento delle Mielolesioni Torino
Netherlands Ziekenhuis Lievensberg, Afdeling Urologie Bergen op Zoom
Netherlands Albert Schweitzer Ziekenhuis, Locatie Dordwijk Dordrecht
Netherlands Catharina Ziekenhuis Eindhoven
Netherlands Radboud Univesity Nijmegen Medical Centre Nijmegen
Sweden Verksamhet Urologi, Sahlgrenska Universitets sjukhuset Göteborg
United Kingdom Sheffield Teaching Hospitals NHS Foundation trust, Royal Hallamshire Hospital Sheffield
United Kingdom Royal National Orthopaedic Hospital, Spinal Injuries Unit, Brockley Hill Stanmore Stanmore

Sponsors (1)

Lead Sponsor Collaborator
Wellspect HealthCare

Countries where clinical trial is conducted

Austria,  Germany,  Italy,  Netherlands,  Sweden,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subject's Perception Regarding Handling of Test Catheter Before Insertion Subject's perception regarding handling of test catheter before insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome) At 4 weeks
Primary Subject's Perception Regarding Handling of Test Catheter at Insertion Subject's perception regarding handling of test catheter at insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome) At 4 weeks
Primary Subject's Perception Regarding Handling of Test Catheter at Withdrawal Subject's perception regarding handling of test catheter at withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome) At 4 weeks
Primary Subject's Perception Regarding Handling of Test Catheter After Withdrawal Subject's perception regarding handling of test catheter after withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome) At 4 weeks
Primary Subject's General Satisfaction With Test Catheter Subject's general satisfaction with test catheter, measured by mean score on a scale from 1 (Very satisfied) to 5 (Absolutely not satified) At 4 weeks
Primary Subject's Sensation When Using Test Catheter Subject's sensation when using test catheter, measured by mean score on a scale from 1 (Comfortable) to 6 (Severe pain) At 4 weeks
See also
  Status Clinical Trial Phase
Terminated NCT00804557 - Efficacy And Safety Of The Uro-Ease® Urinary Catheter During Clean Intermittent Catheterization N/A
Active, not recruiting NCT03459963 - Risks and Benefits of Urinary Catheter in Elective Cesarean Section N/A
Suspended NCT06217016 - Effect of ICCAUT Strategy on Postoperative Urinary Retention After Radical Rectal Cancer Surgery (ICCAUT-2) N/A
Recruiting NCT06241703 - Effect of ICCAUT Strategy on Postoperative Urinary Dysfunction After Radical Rectal Cancer Surgery N/A
Not yet recruiting NCT04159077 - REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial Phase 3
Withdrawn NCT01063452 - Impact of Atkinson Product Design Urinary Slide Valve Versus Standard Catheter Drainage System on Social Functioning Phase 4
Not yet recruiting NCT05710731 - The Urinary Catheterization Training on Skills, Satisfaction and Self-Confidence in Nursing Students N/A
Completed NCT00748033 - A Study Evaluating a Urinary Catheter With Different Activation Times for the Wetting Solution, in Healthy Male Volunteers. N/A